Onconetix, Inc. (ONCO)
0.9962
+0.26
(+34.80%)
USD |
NASDAQ |
Sep 04, 16:00
0.813
-0.18
(-18.39%)
After-Hours: 20:00
Onconetix Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.0039M |
| September 30, 2024 | -0.0023M |
| June 30, 2024 | -0.0177M |
| March 31, 2024 | -0.0046M |
| December 31, 2023 | 1.216M |
| September 30, 2023 | 0.173M |
| Date | Value |
|---|---|
| June 30, 2023 | -10.04M |
| March 31, 2023 | -0.0018M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.0041M |
| March 31, 2022 | -0.0052M |
| December 31, 2021 | -0.0019M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0039M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | 17.89M |
| Aprea Therapeutics, Inc. | -0.0152M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.918M |
| Cash from Financing (Quarterly) | 4.168M |
| Free Cash Flow | -10.31M |
| Free Cash Flow Per Share (Quarterly) | -0.8552 |
| Free Cash Flow to Equity (Quarterly) | -1.815M |
| Free Cash Flow to Firm (Quarterly) | -1.914M |
| Free Cash Flow Yield | -1.75K% |